HOME PAGE

SeniorHealthWeek
Alzheimer's
Arthritis
Bladder Control
Breast Cancer
Cholesterol
Colorectal Cancer
Depression
Diabetes
Eye Disease
Acid Reflux - Ulcers
Heart Disease
Hypertension
Joint Replacement
Lung Cancer
Menopause
Osteoporosis
Parkinson's
Prostate Cancer
Skin Cancer

 

 

 

 

 

 

 

 

Senior Health Report: Prostate Cancer
Health News You Can Use •

Prostate Cancer News:

Low-Fat Diet, Exercise, Stress Reduction May Combat Early Prostate Cancer

A California researcher reports that a study of 84 men suggests that a low-fat diet, plus lifestyle changes, may slow or reverse the progression of prostate cancer in patients with early-stage disease.

Dr. Dean Ornish, a University of California, San Francisco professor and cardiologist who has long promoted low-fat diets to combat heart disease, presented his findings at the Harvard University Scientific Conference on Complementary, Alternative & Integrative Medicine.

The men in the study, all newly diagnosed with prostate specific antigen (PSA) levels between 4 and 10 and "moderate" Gleason scores of under 7, decided to forego medical treatments and employ a strategy known as "watchful waiting."

Half the men were assigned to a control group in which their condition was simply monitored. The other half adopted Ornish's regimen of lifestyle changes, including a low-fat diet consisting mostly of plant-based foods such as fruits, vegetables, grains, beans, and soybeans. Participants also walked a half hour a day, took part in daily stress reduction exercises such as yoga, meditation or stretching, and attended a weekly support group meeting.

While those in the control group saw no changes in their PSA scores after three months, those in the Ornish program saw their scores drop, on average, from 6.3 to 5.7, he reported. After one year, the scores of those in the control group had increased, while those of the subjects in the Ornish group remained lower.

None of the men in the low-fat diet group underwent surgery or radiation during the study period, but seven of those in the control group did.

A number of cancer specialists suggested that the study be viewed with caution.

Dr. Joel B. Nelson, chairman of urology at the University of Pittsburgh School of Medicine, observed that the number of men in the study was small and the results did not show that anyone was cured.

"Although a decline in production of PSA would be consistent with a tumor that is behaving in [a non-aggressive] fashion, it certainly doesn't prove that the cancer wouldn't progress," he said.

Ornish himself said he was not encouraging patients to use his program instead of conventional treatment, but said they might want to discuss it with their doctors and consider it as a possible adjunct to their treatment.

Source: Prostate Cancer Week of April 21, 2002

 

 

About This Site
Privacy Policy
Advertising Policy
Contact Us

USE OF THIS SITE SIGNIFIES ACCEPTANCE OF THIS USER AGREEMENT: The information provided in this and our other sites is for educational purposes only, and it is not intended nor implied to be a substitute for professional medical advice. Always consult your own physician or healthcare provider with any questions you may have regarding a medical condition. Hypertext links to other sites are for the convenience of our Web site viewers and do not constitute any endorsement. We are not responsible for the content of linked sites in any way. This site is intended for personal use only and may not be used for any commercial purpose.